Aura Biosciences, Inc. 10-Q filing
Filed 2025-11-13 · Report date 2025-09-30 · 2025
Filing metadata
- Accession number
- 0001193125-25-278817
- Form type
- 10-Q
- CIK
- 0001501796
- Primary document
- https://www.sec.gov/Archives/edgar/data/1501796/000119312525278817/aura-20250930.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Aura Biosciences, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-85.6M | - | - |
| Net Income | $-80.6M | - | - |
| Eps Basic | -1.39 | - | - |
| Eps Diluted | -1.39 | - | - |
| Cash And Equivalents | $47.6M | - | - |
| Total Assets | $190.0M | - | - |
| Total Liabilities | $33.4M | - | - |
| Shareholders Equity | $156.7M | - | - |
| Operating Cash Flow | $-64.3M | - | - |
| Capital Expenditures | $271,000 | - | - |